Plain-English translation of NCT07321509 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether , an older heart medication used at low doses, can help patients feel better and stay healthier after being hospitalized for acute heart failure. You would receive either this medication plus your usual heart care, or your usual care alone. The study wants to see if the medication helps you feel more energetic, walk farther, and stay out of the hospital over the next six months.
Even with modern heart failure treatments, many patients continue to struggle with fatigue, shortness of breath, and repeated hospitalizations after a heart crisis. This study is exploring whether this medication, which hasn't been thoroughly studied in this setting in recent years, might help improve symptoms and quality of life.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either receive the medication plus your usual heart care, or to continue with your usual care alone. You'll have visits over six months where doctors will check your heart health, measure how far you can walk, take blood tests, and ask how you're feeling. The study is designed to see whether adding this treatment helps you feel better, have more energy, and avoid going back to the hospital.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
Argentina